Viking Therapeutics announced the start of a clinical trial evaluating oral maintenance dosing of VK2735 in patients with obesity. The study is designed to assess the drug's effect on weight maintenance after initial weight loss.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
